# Safety, Tolerability, and Pharmacokinetics of Sulopenem in Adolescents

> **NCT04700787** · PHASE1 · WITHDRAWN · sponsor: **Iterum Therapeutics, International Limited**

## Conditions studied

- Urinary Tract Infections
- Pyelonephritis Acute
- Intraabdominal Infections

## Interventions

- **DRUG:** Sulopenem

## Key facts

- **NCT ID:** NCT04700787
- **Lead sponsor:** Iterum Therapeutics, International Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2021-04-30
- **Primary completion:** 2022-03-25
- **Final completion:** 2022-04-04
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Enrollment challenges and change in development plan necessitating a change in study design
- **Last updated:** 2022-06-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04700787

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04700787, "Safety, Tolerability, and Pharmacokinetics of Sulopenem in Adolescents". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04700787. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*